| Staurosporine | IC50 | 1.2 [1] |
| Isogranulatimide | IC50 | 100.0 [1] |
| Debromohymenialdisine | IC50 | 330.0 [1], 725.0 [2], 3000.0 [3] |
| Granulatimide | IC50 | 80.0 [1], 81.0 [2], 250.0 [3] |
| (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide | IC50 | 5.0 [1], 6.0 [2], 7.89 [3] |
| 4-[4-(6,7-Dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenyl]phenol | IC50 | 1.6 [1], 2.0 [2] |
| 4-[4-(6,7-Dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenyl]phenol | Ki | 1.58 [1] |
| 2-(Carbamoylamino)-5-Phenyl-N-[(3s)-Piperidin-3-Yl]thiophene-3-Carboxamide | IC50 | 7.0 [1] |
| 4-(6-{[(4-Methylcyclohexyl)amino]methyl}-1,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)benzoic Acid | IC50 | 20.0 [1], 22.0 [2] |
| 4-(6-{[(4-Methylcyclohexyl)amino]methyl}-1,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)benzoic Acid | Ki | 19.95 [1] |
| 9-Hydroxy-4-phenyl-6H-pyrrolo[3,4-C]carbazole-1,3-dione | IC50 | 47.0 [1] |
| (R)-5-(8-Chloroisoquinolin-3-Ylamino)-3-(1-(Dimethylamino)propan-2-Yloxy)pyrazine-2-Carbonitrile | IC50 | 6.1 [1], 13.0 [2], 55.0 [3] |
| Hymenialdisine Analogue 1 | IC50 | 234.0 [1], 237.0 [2], 470.0 [3] |
| CID 54758482 | IC50 | 6.0 [1], 7.7 [2], 29.0 [3] |
| Bis-imide A | IC50 | 20.0 [1] |
| (3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-2H-indol-2-one | IC50 | 7.0 [1] |
| (3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-2H-indol-2-one | Ki | 31.62 [1] |
| 7-Chloro-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | IC50 | 7.0 [1], 11.0 [2] |
| 3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-Carboxamide | IC50 | 6.2 [1] |
| 3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-Carboxamide | Ki | 6.31 [1] |
| 7-Chloro-3-oxo-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5(10),6,8,17(21),18-hexaene-18-carbonitrile | IC50 | 6.0 [1] |
| 9-(3-Methoxy-4-nitrophenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one | IC50 | 10.0 [1] |
| 9-(3-Methoxy-4-nitrophenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one | Ki | 10.0 [1] |
| Methyl 6-((5-cyanopyrazin-2-yl)amino)-4-((piperidin-4-ylmethyl)amino)nicotinate | IC50 | 21.0 [1], 36.0 [2], 825.0 [3] |
| 3-[4-(4-Methylpiperazin-1-Yl)phenyl]-9h-Pyrrolo[2,3-B:5,4-C']dipyridine-6-Carbonitrile | IC50 | 1.3 [1], 98.0 [2] |
| 3-[(2R)-1-(Dimethylamino)propan-2-yl]oxy-5-[[4-(methylamino)-5-(1-methylpyrazol-4-yl)pyridin-2-yl]amino]pyrazine-2-carbonitrile | IC50 | 3.1 [1], 8.0 [2], 27.0 [3] |
| (2S,3R,4R,6R,18S)-18-Hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | IC50 | 5.6 [1], 10.0 [2] |
| Hymenialdisine | IC50 | 1900.0 [1], 1950.0 [2] |
| Wee1 Inhibitor | IC50 | 440.0 [1] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | IC50 | 4200.0 [1] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | Ki | 5011.87 [1] |
| 4-(2,6-Dichlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | IC50 | 1200.0 [1] |
| 2-[(5,6-Diphenylfuro[2,3-D]pyrimidin-4-YL)amino]ethanol | IC50 | 20900.0 [1] |
| 2-[(5,6-Diphenylfuro[2,3-D]pyrimidin-4-YL)amino]ethanol | Ki | 13700.0 [1] |
| 4-(2-Chlorophenyl)-9-hydroxy-6-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | IC50 | 220.0 [1] |
| Wee1 Inhibitor II | IC50 | 35000.0 [1] |
| 9-Hydroxy-6-methyl-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | IC50 | 56.0 [1] |
| 1-(5-Chloro-2,4-Dimethoxyphenyl)-3-(5-Cyanopyrazin-2-Yl)urea | IC50 | 7.0 [1] |
| 1-(5-Chloro-2,4-Dimethoxyphenyl)-3-(5-Cyanopyrazin-2-Yl)urea | Ki | 10.0 [1] |
| 4-(2-Chlorophenyl)-9-hydroxy-6-(3-hydroxypropyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | IC50 | 170.0 [1] |
| (1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamine | IC50 | 16000.0 [1] |
| 9-(4-Hydroxy-3-methoxyphenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one | IC50 | 82.0 [1] |
| 9-(4-Hydroxy-3-methoxyphenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one | Ki | 79.43 [1] |
| 4-(6-(Morpholinomethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)benzoic acid | IC50 | 7.9 [1] |
| 4-(6-(Morpholinomethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)benzoic acid | Ki | 7.94 [1] |
| 3-[5-Chloro-2-(oxolan-3-yloxy)phenyl]-1-(5-cyanopyrazin-2-yl)urea | IC50 | 3.0 [1] |
| 3-[5-Chloro-2-(oxolan-3-yloxy)phenyl]-1-(5-cyanopyrazin-2-yl)urea | Ki | 3.16 [1] |
| 7-Chloro-3-oxo-8-(pyridin-4-ylmethylamino)-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | IC50 | 13.0 [1] |
| 7-Chloro-3-oxo-8-(pyridin-4-ylmethylamino)-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 12.59 [1] |
| 18-Chloro-11,12,13,14-Tetrahydro-1h,10h-8,4-(Azeno)-9,15,1,3,6-Benzodioxatriazacycloheptadecin-2-One | IC50 | 10.0 [1] |
| 18-Chloro-11,12,13,14-Tetrahydro-1h,10h-8,4-(Azeno)-9,15,1,3,6-Benzodioxatriazacycloheptadecin-2-One | Ki | 7.94 [1] |
| (S)-2-Phenyl-4-(piperidin-3-ylamino)thieno[3,2-c]pyridine-7-carboxamide | IC50 | 4.0 [1], 7.0 [2] |
| 4,9,19-Triazapentacyclo[10.7.0.02,6.07,11.013,18]nonadeca-1(12),2(6),7(11),13,15,17-hexaene-3,5,10-trione | IC50 | 50.0 [1], 51.0 [2] |
| 3-(4'-Hydroxybiphenyl-4-Yl)-2,4-Dihydroindeno[1,2-C]pyrazol-6-Ol | IC50 | 4.4 [1] |
| 3-(4'-Hydroxybiphenyl-4-Yl)-2,4-Dihydroindeno[1,2-C]pyrazol-6-Ol | Ki | 6.31 [1] |
| 4-[4-[6-(Hydroxymethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl]phenyl]phenol | IC50 | 7.7 [1] |
| 4-[4-[6-(Hydroxymethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl]phenyl]phenol | Ki | 7.94 [1] |
| 3-[5-(Morpholin-4-ylmethyl)-1h-indol-2-yl]-1h-indazole-6-carbonitrile | IC50 | 30.0 [1] |
| 8-Hydroxy-6,9,19-triazapentacyclo[10.7.0.02,6.07,11.013,18]nonadeca-1(19),2,4,7,11,13,15,17-octaen-10-one | IC50 | 24.0 [1] |
| 4'-[7-(Hydroxymethyl)-2,4-Dihydroindeno[1,2-C]pyrazol-3-Yl]biphenyl-4-Ol | IC50 | 4.4 [1] |
| 4'-[7-(Hydroxymethyl)-2,4-Dihydroindeno[1,2-C]pyrazol-3-Yl]biphenyl-4-Ol | Ki | 3.98 [1] |
| 4-(6-(((1r,4r)-4-Methylcyclohexylamino)methyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenol | IC50 | 124.0 [1] |
| 4-(6-(((1r,4r)-4-Methylcyclohexylamino)methyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenol | Ki | 125.89 [1] |
| 4-[4-[5-(Hydroxymethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl]phenyl]phenol | IC50 | 7.8 [1] |
| 4-[4-[5-(Hydroxymethyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl]phenyl]phenol | Ki | 7.94 [1] |
| 4-(5-(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)pyridin-2-yl)phenol | IC50 | 0.5 [1] |
| 4-(5-(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)pyridin-2-yl)phenol | Ki | 0.25 [1] |
| 2-[[3-[4-(4-Hydroxyphenyl)phenyl]-7-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-6-yl]oxy]propane-1,3-diol | IC50 | 0.1 [1] |
| 2-[[3-[4-(4-Hydroxyphenyl)phenyl]-7-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-6-yl]oxy]propane-1,3-diol | Ki | 0.1 [1] |
| N-(4-Morpholin-4-ylpyridin-2-yl)-5-(5-pyrimidin-5-ylpyridin-3-yl)-1,3-thiazol-2-amine | IC50 | 37.0 [1] |
| N-(4-Piperazin-1-ylpyridin-2-yl)-5-[5-(1H-pyrazol-4-yl)pyridin-3-yl]-1,3-thiazol-2-amine | IC50 | 8.0 [1] |
| 5-[2-[[4-(4-Acetylpiperazin-1-yl)pyridin-2-yl]amino]-1,3-thiazol-5-yl]-N-(2-aminoethyl)pyridine-3-carboxamide | IC50 | 0.03 [1] |
| N-(2-Aminoethyl)-5-[2-[[4-(4-methylsulfonylpiperazin-1-yl)pyridin-2-yl]amino]-1,3-thiazol-5-yl]pyridine-3-carboxamide | IC50 | 0.03 [1] |
| N-(2-Aminoethyl)-5-[2-[(4-morpholin-4-ylpyridin-2-yl)amino]-1,3-thiazol-5-yl]pyridine-3-carboxamide | IC50 | 0.05 [1] |
| 3-Methyl-N-[3-(1-methylpyrazol-4-yl)-5-piperidin-3-ylpyrazolo[1,5-a]pyrimidin-7-yl]-1,2-thiazol-5-amine | IC50 | 9.0 [1] |
| 5-(6-Methylpyridin-3-yl)-N-(4-piperazin-1-ylpyridin-2-yl)-1,3-thiazol-2-amine | IC50 | 37.0 [1] |
| 7-Chloro-3-oxo-11,18-dioxa-2,4,21,23-tetrazatricyclo[17.3.1.05,10]tricosa-1(22),5(10),6,8,19(23),20-hexaene-20-carbonitrile | IC50 | 28.0 [1] |
| 4,14-Diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1,6,9,12,15,17,19-heptaene-3,5,8,11-tetrone | IC50 | 269.0 [1] |
| 8,11-Dihydroxy-4,14-diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1(13),2(6),7,9,11,15,17,19-octaene-3,5-dione | IC50 | 311.0 [1] |
| 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(5-cyanopyrazin-2-yl)urea | IC50 | 5.0 [1] |
| 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(5-cyanopyrazin-2-yl)urea | Ki | 3.98 [1] |
| 2-(2,3-Dihydro-1-Benzofuran-5-Yl)-N-[2-(Piperazin-1-Yl)phenyl]-1,3-Thiazole-4-Carboxamide | IC50 | 75.0 [1] |
| 8-Chloro-5,10-Dihydro-11h-Dibenzo[b,E][1,4]diazepin-11-One | IC50 | 17000.0 [1] |
| 8-Chloro-5,10-Dihydro-11h-Dibenzo[b,E][1,4]diazepin-11-One | Ki | 15848.93 [1] |
| Ethyl 4-[2-(aminomethyl)morpholin-4-yl]-1H-pyrazolo[3,4-b]pyridine-5-carboxylate | IC50 | 1000.0 [1], 1200.0 [2] |
| 5-(6,7-Dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)pyridine-2-carbonitrile | IC50 | 0.8 [1], 0.81 [2] |
| 6,7-Dimethoxy-3-[4-(1h-Tetrazol-5-Yl)phenyl]-1,4-Dihydroindeno[1,2-C]pyrazole | IC50 | 11.0 [1] |
| 6,7-Dimethoxy-3-[4-(1h-Tetrazol-5-Yl)phenyl]-1,4-Dihydroindeno[1,2-C]pyrazole | Ki | 12.59 [1] |
| 4-[(6,7-Dimethoxy-2,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)ethynyl]-2-Methoxyphenol | IC50 | 5.0 [1] |
| 4-[(6,7-Dimethoxy-2,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)ethynyl]-2-Methoxyphenol | Ki | 5.01 [1] |
| (13Z)-8-Amino-7-chloro-3-oxo-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5(10),6,8,13,17(21),18-heptaene-18-carbonitrile | IC50 | 0.3 [1] |
| (13Z)-8-Amino-7-chloro-3-oxo-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5(10),6,8,13,17(21),18-heptaene-18-carbonitrile | Ki | 0.32 [1] |
| 5-Methyl-8-(1h-Pyrrol-2-Yl)[1,2,4]triazolo[4,3-A]quinolin-1(2h)-One | IC50 | 0.1 [1] |
| 8-[4-(Hydroxymethyl)phenyl]-5-methyl-2H-[1,2,4]triazolo[4,3-a]quinolin-1-one | IC50 | 10.0 [1] |
| 5-Methyl-8-(thiophen-2-yl)-[1,2,4]triazolo[4,3-a]quinolin-1(2H)-one | IC50 | 20.0 [1] |
| 3-(1-Methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine | IC50 | 60.0 [1] |
| 3-Bromo-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine | IC50 | 1080.0 [1] |
| 1-Morpholin-4-yl-2-[4-[2-[(5-pyridin-3-yl-1,3-thiazol-2-yl)amino]pyridin-4-yl]piperazin-1-yl]ethanone | IC50 | 47.0 [1] |
| N-(4-Morpholin-4-ylpyridin-2-yl)-5-(5-pyridin-3-ylpyridin-3-yl)-1,3-thiazol-2-amine | IC50 | 19.0 [1] |
| 5-Methyl[1,2,4]triazolo[4,3-a]quinolin-1(2h)-one | IC50 | 800.0 [1] |